Smooth Muscle Cell-Specific Genetic Targeting by Myh11-driven Cre(ER) Knockin Mice

Enci Wang,Ximeng Han,Haixiao Wang,Kathy O. Lui,Bin Zhou,Lixin Wang
DOI: https://doi.org/10.1007/s11427-023-2546-3
2024-01-01
Science China Life Sciences
Abstract:>Dear editor,Site specific recombinases have been widely used for genome engineering in cardiovascular research(Fu et al., 2024;Huang et al., 2023; Xue et al., 2022). In particular, Cre is the most broadly used recombinase for cell type-specific lineage tracing and gene manipulation in mammals. For smooth muscle cell(SMC)-specific targeting, several SMC promoters including Myh11(smooth muscle myosin heavy chain), Acta2(smooth muscle a-2 actin), and SM22a(Tagln) have been used to drive Cre or CreER.
What problem does this paper attempt to address?